Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:3104-3111

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukumoto, Y.
Right arrow Articles by Takeshita, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukumoto, Y.
Right arrow Articles by Takeshita, A.

(Circulation. 1997;96:3104-3111.)
© 1997 American Heart Association, Inc.


Articles

Vasculoprotective Role of Inducible Nitric Oxide Synthase at Inflammatory Coronary Lesions Induced by Chronic Treatment With Interleukin-1ß in Pigs in Vivo

Yoshihiro Fukumoto, MD; Hiroaki Shimokawa, MD; Toshiyuki Kozai, MD; Toshiaki Kadokami, MD; Kouichi Kuwata, MD; Yoshikazu Yonemitsu, MD; Takeshi Kuga, MD; Kensuke Egashira, MD; Katsuo Sueishi, MD; ; Akira Takeshita, MD

From the Research Institute of Angiocardiology and Cardiovascular Clinic and the First Department of Pathology (Y.Y., K.S.), Kyushu University School of Medicine, Fukuoka, Japan.

Correspondence to Hiroaki Shimokawa, MD, The Research Institute of Angiocardiology and Cardiovascular Clinic, Kyushu University School of Medicine, 3–1-1 Maidashi, Higashi-ku, Fukuoka 812–82, Japan.

Background We recently developed a porcine model in which chronic, local treatment with interleukin-1ß (IL-1ß) causes coronary arteriosclerotic changes and hyperconstrictive responses. Inflammatory cytokines are known to induce inducible NO synthase (iNOS) in the vascular smooth muscle. This study was designed to examine whether or not the production of NO by iNOS has a protective or deleterious effect on the coronary artery in vivo.

Methods and Results A segment of the porcine coronary artery was aseptically wrapped with cotton mesh absorbing IL-1ß suspension. We inhibited both eNOS and iNOS activity by cotreatment with L-NAME (a nonspecific inhibitor of NOS) and iNOS activity alone by aminoguanidine (a selective inhibitor of iNOS). Immunostaining showed that iNOS was absent in the normal coronary artery, whereas it was highly expressed 1 day after the application of IL-1ß and thereafter downregulated until 14 days. In contrast, eNOS was well maintained throughout the study period. Two weeks after the operation, hyperconstrictive responses to intracoronary serotonin and neointimal formation were noted at the IL-1ß–treated site, and both responses were significantly greater at the site cotreated with either L-NAME or aminoguanidine.

Conclusions These results indicate that iNOS is transiently induced in vivo in response to local inflammation and that NO produced by iNOS exerts an inhibitory effect against the cytokine-induced proliferative/vasospastic changes of the coronary artery in vivo.


Key Words: endothelium-derived factors • nitric oxide synthase • arteriosclerosis • vasospasm




This article has been cited by other articles:


Home page
FASEB J.Home page
V. I. Patel, S. Daniel, C. R. Longo, G. V. Shrikhande, S. T. Scali, E. Czismadia, C. M. Groft, T. Shukri, C. Motley-Dore, H. E. Ramsey, et al.
A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia
FASEB J, July 1, 2006; 20(9): 1418 - 1430.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C.-Y. Wei, K.-C. Huang, Y.-H. Chou, P.-F. Hsieh, K.-H. Lin, and W.-W. Lin
The Role of Rho-Associated Kinase in Differential Regulation by Statins of Interleukin-1beta- and Lipopolysaccharide-Mediated Nuclear Factor {kappa}B Activation and Inducible Nitric-Oxide Synthase Gene Expression in Vascular Smooth Muscle Cells
Mol. Pharmacol., March 1, 2006; 69(3): 960 - 967.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Hayashi, D. Sumi, P. A.R Juliet, H. Matsui-Hirai, Y. Asai-Tanaka, H. Kano, A. Fukatsu, T. Tsunekawa, A. Miyazaki, A. Iguchi, et al.
Gene transfer of endothelial NO synthase, but not eNOS, plus inducible NOS regressed atherosclerosis in rabbits
Cardiovasc Res, February 1, 2004; 61(2): 339 - 351.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Fukumoto, H. Tsutsui, M. Tsuchihashi, A. Masumoto, A. Takeshita, and Cholesterol Embolism Study(CHEST) Investigators
The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study
J. Am. Coll. Cardiol., July 16, 2003; 42(2): 211 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Park, J.-Y. Byun, C. Kramers, J. I. Kim, P. L. Huang, and J. V. Bonventre
Inducible Nitric-oxide Synthase Is an Important Contributor to Prolonged Protective Effects of Ischemic Preconditioning in the Mouse Kidney
J. Biol. Chem., July 11, 2003; 278(29): 27256 - 27266.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Kandabashi, H. Shimokawa, Y. Mukai, T. Matoba, I. Kunihiro, K. Morikawa, M. Ito, S. Takahashi, K. Kaibuchi, and A. Takeshita
Involvement of Rho-Kinase in Agonists-Induced Contractions of Arteriosclerotic Human Arteries
Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 243 - 248.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Yogo, H. Shimokawa, H. Funakoshi, T. Kandabashi, K. Miyata, S. Okamoto, K. Egashira, P. Huang, T. Akaike, and A. Takeshita
Different Vasculoprotective Roles of NO Synthase Isoforms in Vascular Lesion Formation in Mice
Arterioscler Thromb Vasc Biol, November 1, 2000; 20 (11): e96 - e100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Muniyappa, R. Xu, J. L. Ram, and J. R. Sowers
Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1762 - H1768.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Ishigami, D. K. Swertfeger, M. S. Hui, N. A. Granholm, and D. Y. Hui
Apolipoprotein E Inhibition of Vascular Smooth Muscle Cell Proliferation but Not the Inhibition of Migration Is Mediated Through Activation of Inducible Nitric Oxide Synthase
Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1020 - 1026.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Kandabashi, H. Shimokawa, K. Miyata, I. Kunihiro, Y. Kawano, Y. Fukata, T. Higo, K. Egashira, S. Takahashi, K. Kaibuchi, et al.
Inhibition of Myosin Phosphatase by Upregulated Rho-Kinase Plays a Key Role for Coronary Artery Spasm in a Porcine Model With Interleukin-1{beta}
Circulation, March 21, 2000; 101(11): 1319 - 1323.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Miyata, H. Shimokawa, T. Yamawaki, I. Kunihiro, X. Zhou, T. Higo, E. Tanaka, N. Katsumata, K. Egashira, and A. Takeshita
Endothelial Vasodilator Function Is Preserved at the Spastic/Inflammatory Coronary Lesions in Pigs
Circulation, September 28, 1999; 100(13): 1432 - 1437.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Depre, X. Havaux, J. Renkin, J. L. J. Vanoverschelde, and W. Wijns
Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque
Cardiovasc Res, February 1, 1999; 41(2): 465 - 472.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Gonzalez-Fernandez, A. Lopez-Farre, J. A. Rodriguez-Feo, J. Farre, J. Guerra, J. Fortes, I. Millas, M. Garcia-Duran, L. Rico, P. Mata, et al.
Expression of Inducible Nitric Oxide Synthase After Endothelial Denudation of the Rat Carotid Artery : Role of Platelets
Circ. Res., November 30, 1998; 83(11): 1080 - 1087.
[Abstract] [Full Text] [PDF]